Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

Jian Chu, Lillian Tung, Issam Atallah, David Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa

Research output: Contribution to journalComment/debatepeer-review

Abstract

BioMed Central 1 5 0 2024 BioMed Central Ltd., part of Springer Nature 2024 No Unnumbered 2024 1 25 0 0 Regular ArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/40959_2024_Article_205.pdf All Typeset OnlinePDF Regular Erratum Medicine & Public Health Oncology Cardiology Medicine true Following publication of the original article [1], the authors identified an error in the author name of Issam Atallah. The incorrect author name is: Issam Attalah. The correct author name is: Issam Atallah. The author group has been updated above and the original article [1] has been corrected.

Original languageEnglish (US)
JournalCardio-Oncology
Volume10
Issue number1
DOIs
StatePublished - Dec 2024

ASJC Scopus subject areas

  • Oncology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)'. Together they form a unique fingerprint.

Cite this